National emergency over HIV in Philippines
Published on: Tuesday, June 10, 2025
Published on: Tue, Jun 10, 2025
By: Philippine Daily Inquirer, ANN Text Size: Health department data showed a total of 148,831 reported HIV cases from January 1984 to March 2025. (Pic: Philippine Daily Inquirer) MANILA: With a 500-percent surge in new human immunodeficiency virus or HIV cases per day, the Philippines now has the fastest-growing number of people living with HIV (PLHIV) in the Western Pacific region. This development is alarming enough to prompt the Department of Health (DOH) to urge President Marcos to declare a national public health emergency.
Advertisement 'With a national public health emergency for HIV, every sector in the society will help to address this. The whole of society, the whole of government can help us in this campaign to reduce the number of new HIV cases,' Health Secretary Teodoro Herbosa said. The HIV surge, Herbosa said, is a 'bigger' problem than mpox (previously known as monkeypox). All of the mpox fatalities in the country died not from mpox itself, but due to complications caused by advanced HIV, he added. The DOH has recorded 57 cases per day from January to March this year, or 5,101 newly diagnosed PLHIV over that period, including a 12-year-old from Palawan province, who was found to have engaged in unprotected sex since an early age. HIV and AIDS (acquired immunodeficiency syndrome) surveillance has shown that Filipinos who are newly diagnosed with HIV are getting younger. The DOH noted that the predominant age group has shifted from 35-49 years old in 2002-2005, to 25-34 years old starting in 2006. The below-15 age group has also seen a 133-percent increase, the highest, followed by 15-24, whose numbers increased by 106 per cent. DOH data showed a total of 148,831 reported HIV cases from January 1984 to March 2025. Sexual contact remained the predominant mode of transmission, but has shifted to men who have sex with men (MSM) since 2007. Herbosa warned that the number of PLHIVs could breach 400,000 cases by the end of 2030 should there be no improvement in the services for HIV/AIDS prevention and PLHIV support. But while a national emergency can help raise awareness, the government must immediately implement concrete solutions to stem the rise in HIV cases especially among the young. Former health secretary Janette Garin, for one, said the government should increase efforts in making medicines available and accessible to prevent widespread infection. She added that the rise in cases was expected because the availability of tests and public awareness have driven the numbers up. The study, 'Exploring the HIV Epidemic in the Philippines: Initiatives and Challenges,' published in January this year, offers additional insights. It said that initiatives like Republic Act No. 11166, or the Philippine HIV and AIDS Policy Act of 2018, strengthen the comprehensive policy on HIV and AIDS prevention, treatment, care, and support. It, however, noted that despite these measures, including the increase in primary HIV care facilities and treatment centers, there still was 'not much improvement [in controlling] the rising HIV cases.' The researchers attributed this to several factors, such as the low use of artificial contraceptives, like condoms and pre-exposure prophylaxis (PrEP), or the use of antiretroviral drugs, to prevent contracting HIV, especially among MSM. The researchers noted that PrEP was available mainly in urban areas but not in the provinces and recommended that health care providers include this service, with the help of private companies and the government. They also cited the Catholic Church's conservatism, which 'greatly influences [and] prevents the full implementation of sexual education in all schools in the country.' The Church has opposed the use of artificial contraceptives and sex education in schools, arguing that parents should be the primary educators in this area. However, as the study pointed out, many parents are not knowledgeable enough to assume this responsibility, especially when conversations on sex remain a taboo in many families. The government can look to Thailand, which has successfully controlled its HIV epidemic through several programs focusing on prevention and care that have evolved since 1984, when their first AIDS case was reported. Among Thailand's notable HIV prevention policies were the 100pc Condom Program, Prevention of Mother-to-Child Transmission, and expansion of antiretroviral therapy coverage, which were all done in partnership with civil society and PLHIV. In the 1990s, Thailand, under the leadership of then-Cabinet member Mechai Viravaidya, launched an intensive public information campaign on HIV/AIDS prevention. This included mandatory one-minute AIDS education spots every hour on television and radio, as well as education programs in schools that raised students' level of awareness. The world today has a better understanding of HIV and AIDS, and together with it, many ways to protect oneself from contracting HIV, or treating it early so that PLHIVs can live a long and healthy life. This is where the government should focus its efforts instead of hyping up numbers that only trigger panic or fear among the public. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.
Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
4 days ago
- The Sun
HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
HONG KONG SAR - Media OutReach Newswire - 17 June 2025 - Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world's largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong's two leading medical faculties—the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) - to form a delegation, showcasing Hong Kong's cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong's position as a world-class biotech innovation hub. The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms. During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities: • Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. • HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth. Mr. Albert Wong, CEO of HKSTP, said: 'We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.' Ahead of BIO 2025, the delegation participated in the '2025 Biomedical Pitch Competition', co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth. HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as 'Edison of Medicine'), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader. Appendix: List of Park Companies Participating in BIO 2025: 1. Allegrow Biotech Limited 2. ARBELE Limited 3. Beth Bioinformatics Co., Limited 4. Centre for Translational Stem Cell Biology 5. The Centre for Virology, Vaccinology, and Therapeutics 6. DECODE CURE Limited 7. GenEditBio Limited 8. Great Bay Bio 9. Hong Kong Universal Biologicals Company Limited 10. Immuno Cure Holding (HK) Limited 11. The Institute for Innovation, Translation and Policy Research (ITPR) 12. LEE'S PHARMACEUTICAL (HK) LIMITED 13. Serilink Biotechnology Company Limited 14. Xiaomo Biotech Limited 15. XUXIN (HongKong) Biotechnology Co., Limited 16. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited Hashtag: #HKSTP
The Star
5 days ago
- The Star
The doctor will be arriving ... in a mailbox
You can now do self-administered tests for everything from thyroid function to Human Immunodeficiency Virus (HIV) in the privacy of your own home – and that list continues to grow, as the United States Food and Drug Administration (FDA) recently approved the first at-home cervical cancer test. While the tests can make it easier for people to access healthcare and can be helpful for those who have extreme anxiety about sensitive or invasive medical exams, experts warn that most of the tests cannot replace an actual in-person visit. Here's what doctors say you can test for at home, and when you should make the trek to your physician's office. There are two kinds at 'at-home tests.' In one type, the patient collects the sample and sends it off to a lab; the new cervical cancer test is like this. The other gives an instant result – think Covid-19 and pregnancy tests. HIV home-testing kits can improve rates of diagnosing sexually transmitted infections (STIs) in rural communities and help people who are nervous about going to the doctor to seek a sensitive test, said Dr Joseph Cherabie, an infectious diseases specialist in St. Louis, Missouri. 'You really want to get people to care as quickly as possible, but some people could be very anxious about that results as well,' Dr Cherabie said. 'And they have very negative reactions.' Labs are required to report a positive HIV test, instead of putting the onus on the patient who took the test, he said, and often, the patient is matched up with HIV support services. 'If you are part of a sexual and gender minority community, going to a doctor's office can be full of a lot of historical trauma, and you may prefer to just do testing at home without anyone judging you or asking you invasive questions about your sex life,' Dr Cherabie said. The new cervical cancer test – which tests for strains of human papillomavirus, or HPV – involves a testing swab that's like a tampon, said Dr Susan Modesitt, a gynaecologic oncologist at Emory University in Atlanta. It is not, she said, a replacement for a Pap smear, the exam in which a metal speculum is inserted in the vagina to scrape cervix cells. A doctor's visit also involves a pelvic exam, a chance to talk about abnormal bleeding – a sign of endometrial cancer – and other symptoms and issues, like menopause or STIs. 'There are so many other reasons to see your doctor and get an exam outside of a cervical cancer screening,' Dr Modesitt said. The at-home cervical cancer test from Teal Health requires a prescription, and the company said that results are not left for the patient to interpret. Colon cancer screening Some at-home tests can replace a trip to the doctor's office. That's especially true in rural areas, where it can be difficult to get a colonoscopy. 'The colonoscopy requires a pre-op, and you have to drive maybe 70 miles (113km) for it,' said Dr Steven Furr, board chair of the American Academy of Family Physicians who practices in rural Alabama. 'You get anaesthesia. It's actually almost like a surgical procedure in many ways. 'So, for a lot of people, that's pretty arduous. That's where an at-home test can come in handy.' But, Dr Furr said, if your test reveals issues, you need to go to your doctor. Plus, patients should always discuss test results with their physician instead of interpreting them on their own, he said. If you have symptoms of what you're testing for, go to the doctor. At-home colon cancer tests aren't the right option for people with a history of colon cancer or high-risk conditions, such as inflammatory bowel disease, said Dr Zachariah Foda, a gastroenterologist at Johns Hopkins. He added that they're also not recommended for people who are having gastrointestinal symptoms. While there are tests for many things – running anywhere from $15 (RM64) to $400 (RM1,693), depending on what is being evaluated – Dr Furr said it's essential to make sure that your test is FDA-approved so you can better trust the results. 'Anytime we get people involved in their own healthcare and help them understand what's going on, I think that's a good thing and it gives us a chance to talk,' he said. 'Any kind of screening is better than no screening.' – AP
The Star
7 days ago
- The Star
Singapore's Covid-19 wave eases as weekly cases and hospitalisation numbers dip
The latest data shows the number of hospitalisations has decreased to about 118 cases daily. -- PHOTO: ST FILE SINGAPORE (The Straits Times/ANN): Singapore's recent Covid-19 wave is easing, with the number of cases dipping to about 15,300 weekly, said Minister of Health Ong Ye Kung. The latest data, which Mr Ong called 'encouraging', also shows the number of hospitalisation cases has decreased to about 118 daily. In his Facebook post on June 14, he added that when the wave first picked up in late April, the Republic saw the estimated weekly infections spike to about 26,400 cases. Healthcare institutions in Singapore also faced increased patient load, with daily Covid-19 hospitalisation cases reaching around 174. 'The good news is that ICU (intensive care unit) cases remained consistently low throughout this wave, staying at just about two to three cases daily,' Ong said. 'This shows how our healthcare system has built up stronger resilience in managing Covid-19.' Amid signs that the wave is slowing down, he said that wastewater surveillance readings have also declined, referring to the quick and accurate barometer to detect diseases. In his post, Ong reminded the public that similar to seasonal influenza, such Covid-19 waves can still put pressure on Singapore's healthcare system. He added that Singaporeans must continue to prepare for new pandemics or future waves. 'We will keep monitoring the situation closely, particularly the emergence of new variants, and update the public accordingly,' he said. - The Straits Times/ANN
